Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05739149

A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers

The purpose of this research is to explore the use of high-resolution microvessel ultrasound imaging system to look for scarring and to monitor wound healing and to see if treatment affects the amount of tiny vessels and circulation around the wound.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic Minnesota

Rochester, Minnesota, 55905, United States

Location status: Recruiting

Location contact

Michael R Moynagh, M.B.B.CH

CONTACT

[email protected]

507-288-2763

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chronic wound in the course of diabetic foot ulcers and/or lower extremity venous ulcers with duration of at least 6 weeks and the wound surface not less than 2 sq. cm and not greater than 15 sq. cm, without evidence of active infection of the wound at the time of qualification to participate in the study
  • Meets criteria for stalled chronic wound defined as less than 50% reduction in wound size after 30 days of standard of care management.
  • For chronic venous ulcers, ultrasound demonstrates venous reflux >0.5 seconds
  • Satisfactory blood glucose control - fasting not more than 110 mg%, HbA1c <6.5%
  • Satisfactory blood supply to the wound verified by the measurement of the oxygen level of the foot tissue (TCPO2 > 30mmHg) in patients with neuropathic etiology of diabetic foot syndrome
  • In the case of the patients with the wounds of ischemic component, the condition for qualification is a clinical improvement of the limb's blood supply as a result of the revascularization procedure documented by ultrasound.
  • Ankle-brachial index (ABI) ≥ 0.8

Exclusion criteria

  • Acute wound with duration less than 6 weeks
  • Evidence of active infection or on antibiotics
  • Smoker
  • For chronic venous ulcers, ultrasound demonstrates venous reflux <0.5 seconds
  • Unsatisfactory blood glucose control - fasting more than 110 mg%, HbA1c <6.5%
  • Poor blood supply to the wound verified by the measurement of the oxygen level of the foot tissue (TCPO2 < 30mmHg) in patients with neuropathic etiology of diabetic foot syndrome
  • Ankle-brachial index (ABI) < 0.
  • Pregnancy
  • Known allergy to lidocaine

Treatment and study plan

Microvessel Ultrasound Examination

Diagnostic Test

Ultrasound to evaluate microvessel formation and elastography or stiffness of the tissues around the ulcer and in an area of unaffected skin

skin biopsy

Procedure

Dermatology will remove a small piece of skin from the affected ulcer area and control skin

Primary outcomes

  1. Microvessel imaging

    Time frame: 3 months

    Number of subject's microvessel imaging results that correlate to the standard of care clinical assessment of wound healing

Study contacts

Contact information is provided by the study sponsor or research team.

Michael R Moynagh, MD

CONTACT

[email protected]

507-266-4755

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Microvessel Ultrasound Imaging of the Skin and Subcutaneous Tissues to Evaluate Wound Healing in Patients With Chronic Ulcers

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Feb 22, 2023
Registry last updated
Jan 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.